nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—Myopathy—Adefovir Dipivoxil—hepatitis B	0.0114	0.0159	CcSEcCtD
Fluvoxamine—Myopathy—Telbivudine—hepatitis B	0.00963	0.0134	CcSEcCtD
Fluvoxamine—Cough increased—Adefovir Dipivoxil—hepatitis B	0.00876	0.0122	CcSEcCtD
Fluvoxamine—Hoarseness—Lamivudine—hepatitis B	0.00865	0.012	CcSEcCtD
Fluvoxamine—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00837	0.0116	CcSEcCtD
Fluvoxamine—SLC6A4—blood plasma—hepatitis B	0.00813	0.0812	CbGeAlD
Fluvoxamine—Rhabdomyolysis—Telbivudine—hepatitis B	0.00763	0.0106	CcSEcCtD
Fluvoxamine—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00753	0.0105	CcSEcCtD
Fluvoxamine—Cardiomyopathy—Lamivudine—hepatitis B	0.00744	0.0103	CcSEcCtD
Fluvoxamine—Neck pain—Telbivudine—hepatitis B	0.00684	0.00949	CcSEcCtD
Fluvoxamine—CYP2C19—blood plasma—hepatitis B	0.00673	0.0672	CbGeAlD
Fluvoxamine—Suicide attempt—Lamivudine—hepatitis B	0.00671	0.00931	CcSEcCtD
Fluvoxamine—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00666	0.00925	CcSEcCtD
Fluvoxamine—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00612	0.0085	CcSEcCtD
Fluvoxamine—CYP1A2—blood plasma—hepatitis B	0.0055	0.0549	CbGeAlD
Fluvoxamine—Myopathy—Lamivudine—hepatitis B	0.00543	0.00754	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00538	0.00746	CcSEcCtD
Fluvoxamine—CYP3A5—blood plasma—hepatitis B	0.0053	0.053	CbGeAlD
Fluvoxamine—CYP2B6—blood plasma—hepatitis B	0.00527	0.0526	CbGeAlD
Fluvoxamine—CYP2C9—blood plasma—hepatitis B	0.00522	0.0521	CbGeAlD
Fluvoxamine—Renal impairment—Telbivudine—hepatitis B	0.00515	0.00715	CcSEcCtD
Fluvoxamine—Pancreatitis—Entecavir—hepatitis B	0.00506	0.00702	CcSEcCtD
Fluvoxamine—CYP2E1—blood plasma—hepatitis B	0.00495	0.0494	CbGeAlD
Fluvoxamine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00493	0.00685	CcSEcCtD
Fluvoxamine—Amblyopia—Lamivudine—hepatitis B	0.00493	0.00684	CcSEcCtD
Fluvoxamine—Hyperaesthesia—Lamivudine—hepatitis B	0.00485	0.00673	CcSEcCtD
Fluvoxamine—Migraine—Telbivudine—hepatitis B	0.00483	0.0067	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Entecavir—hepatitis B	0.00479	0.00666	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Entecavir—hepatitis B	0.00465	0.00646	CcSEcCtD
Fluvoxamine—Dysphonia—Lamivudine—hepatitis B	0.00463	0.00642	CcSEcCtD
Fluvoxamine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00455	0.00632	CcSEcCtD
Fluvoxamine—Acne—Lamivudine—hepatitis B	0.00452	0.00628	CcSEcCtD
Fluvoxamine—Renal failure—Entecavir—hepatitis B	0.00452	0.00628	CcSEcCtD
Fluvoxamine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00441	0.00612	CcSEcCtD
Fluvoxamine—Haematuria—Entecavir—hepatitis B	0.00438	0.00609	CcSEcCtD
Fluvoxamine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00437	0.00607	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Entecavir—hepatitis B	0.00435	0.00604	CcSEcCtD
Fluvoxamine—Gastritis—Telbivudine—hepatitis B	0.00434	0.00602	CcSEcCtD
Fluvoxamine—Muscular weakness—Telbivudine—hepatitis B	0.00432	0.006	CcSEcCtD
Fluvoxamine—CYP3A7—liver—hepatitis B	0.00432	0.0431	CbGeAlD
Fluvoxamine—Rhabdomyolysis—Lamivudine—hepatitis B	0.0043	0.00597	CcSEcCtD
Fluvoxamine—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00428	0.00594	CcSEcCtD
Fluvoxamine—Abdominal distension—Telbivudine—hepatitis B	0.00427	0.00592	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00424	0.00589	CcSEcCtD
Fluvoxamine—Influenza—Telbivudine—hepatitis B	0.00424	0.00588	CcSEcCtD
Fluvoxamine—Bone disorder—Lamivudine—hepatitis B	0.00421	0.00585	CcSEcCtD
Fluvoxamine—Rectal haemorrhage—Lamivudine—hepatitis B	0.00421	0.00585	CcSEcCtD
Fluvoxamine—Viral infection—Lamivudine—hepatitis B	0.00421	0.00585	CcSEcCtD
Fluvoxamine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00421	0.00585	CcSEcCtD
Fluvoxamine—Hepatitis—Entecavir—hepatitis B	0.00413	0.00573	CcSEcCtD
Fluvoxamine—Drug interaction—Lamivudine—hepatitis B	0.0041	0.0057	CcSEcCtD
Fluvoxamine—Oedema peripheral—Entecavir—hepatitis B	0.00407	0.00565	CcSEcCtD
Fluvoxamine—Abdominal discomfort—Telbivudine—hepatitis B	0.00406	0.00564	CcSEcCtD
Fluvoxamine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00403	0.00559	CcSEcCtD
Fluvoxamine—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00402	0.00559	CcSEcCtD
Fluvoxamine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.004	0.00555	CcSEcCtD
Fluvoxamine—CYP3A4—blood plasma—hepatitis B	0.00398	0.0398	CbGeAlD
Fluvoxamine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00398	0.00552	CcSEcCtD
Fluvoxamine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00395	0.00548	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00394	0.00547	CcSEcCtD
Fluvoxamine—CYP2D6—blood plasma—hepatitis B	0.00392	0.0391	CbGeAlD
Fluvoxamine—Vasculitis—Lamivudine—hepatitis B	0.0039	0.00541	CcSEcCtD
Fluvoxamine—Muscle twitching—Lamivudine—hepatitis B	0.00388	0.00538	CcSEcCtD
Fluvoxamine—Eructation—Lamivudine—hepatitis B	0.00374	0.00519	CcSEcCtD
Fluvoxamine—Renal failure—Telbivudine—hepatitis B	0.00371	0.00516	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Telbivudine—hepatitis B	0.0037	0.00514	CcSEcCtD
Fluvoxamine—CYP3A7-CYP3A51P—liver—hepatitis B	0.00367	0.0367	CbGeAlD
Fluvoxamine—Alopecia—Entecavir—hepatitis B	0.00365	0.00507	CcSEcCtD
Fluvoxamine—Mental disorder—Entecavir—hepatitis B	0.00362	0.00502	CcSEcCtD
Fluvoxamine—Malnutrition—Entecavir—hepatitis B	0.00359	0.00499	CcSEcCtD
Fluvoxamine—Neuropathy—Lamivudine—hepatitis B	0.00357	0.00496	CcSEcCtD
Fluvoxamine—Photophobia—Lamivudine—hepatitis B	0.00357	0.00496	CcSEcCtD
Fluvoxamine—Aplastic anaemia—Lamivudine—hepatitis B	0.00357	0.00496	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00357	0.00496	CcSEcCtD
Fluvoxamine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00351	0.00487	CcSEcCtD
Fluvoxamine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00346	0.0048	CcSEcCtD
Fluvoxamine—Mouth ulceration—Lamivudine—hepatitis B	0.00344	0.00478	CcSEcCtD
Fluvoxamine—Urine output increased—Lamivudine—hepatitis B	0.00344	0.00478	CcSEcCtD
Fluvoxamine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00339	0.00471	CcSEcCtD
Fluvoxamine—Hepatitis—Telbivudine—hepatitis B	0.00339	0.00471	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Telbivudine—hepatitis B	0.00337	0.00469	CcSEcCtD
Fluvoxamine—Pharyngitis—Telbivudine—hepatitis B	0.00337	0.00467	CcSEcCtD
Fluvoxamine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00324	0.0045	CcSEcCtD
Fluvoxamine—Lymphadenopathy—Lamivudine—hepatitis B	0.00324	0.0045	CcSEcCtD
Fluvoxamine—Leukopenia—Entecavir—hepatitis B	0.00322	0.00447	CcSEcCtD
Fluvoxamine—Phlebitis—Lamivudine—hepatitis B	0.00321	0.00445	CcSEcCtD
Fluvoxamine—Sleep disorder—Lamivudine—hepatitis B	0.00319	0.00443	CcSEcCtD
Fluvoxamine—Polyuria—Lamivudine—hepatitis B	0.00315	0.00437	CcSEcCtD
Fluvoxamine—Gastroenteritis—Lamivudine—hepatitis B	0.00312	0.00433	CcSEcCtD
Fluvoxamine—Deafness—Lamivudine—hepatitis B	0.00309	0.00429	CcSEcCtD
Fluvoxamine—Cough—Adefovir Dipivoxil—hepatitis B	0.00306	0.00425	CcSEcCtD
Fluvoxamine—Injury—Lamivudine—hepatitis B	0.00301	0.00417	CcSEcCtD
Fluvoxamine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00299	0.00415	CcSEcCtD
Fluvoxamine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00299	0.00415	CcSEcCtD
Fluvoxamine—SLC6A4—blood—hepatitis B	0.00298	0.0297	CbGeAlD
Fluvoxamine—SIGMAR1—blood—hepatitis B	0.00296	0.0295	CbGeAlD
Fluvoxamine—Malnutrition—Telbivudine—hepatitis B	0.00295	0.0041	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Entecavir—hepatitis B	0.00293	0.00407	CcSEcCtD
Fluvoxamine—Infection—Entecavir—hepatitis B	0.00291	0.00405	CcSEcCtD
Fluvoxamine—Renal impairment—Lamivudine—hepatitis B	0.0029	0.00403	CcSEcCtD
Fluvoxamine—Thirst—Lamivudine—hepatitis B	0.0029	0.00403	CcSEcCtD
Fluvoxamine—Dysgeusia—Telbivudine—hepatitis B	0.00289	0.00401	CcSEcCtD
Fluvoxamine—Nervous system disorder—Entecavir—hepatitis B	0.00288	0.00399	CcSEcCtD
Fluvoxamine—Back pain—Telbivudine—hepatitis B	0.00286	0.00397	CcSEcCtD
Fluvoxamine—Muscle spasms—Telbivudine—hepatitis B	0.00284	0.00394	CcSEcCtD
Fluvoxamine—Hypoglycaemia—Lamivudine—hepatitis B	0.00283	0.00393	CcSEcCtD
Fluvoxamine—ABCB1—blood plasma—hepatitis B	0.00282	0.0281	CbGeAlD
Fluvoxamine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00281	0.0039	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.0028	0.00389	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Telbivudine—hepatitis B	0.00274	0.0038	CcSEcCtD
Fluvoxamine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00273	0.00379	CcSEcCtD
Fluvoxamine—Migraine—Lamivudine—hepatitis B	0.00272	0.00378	CcSEcCtD
Fluvoxamine—Affect lability—Lamivudine—hepatitis B	0.00272	0.00378	CcSEcCtD
Fluvoxamine—Malaise—Telbivudine—hepatitis B	0.00266	0.0037	CcSEcCtD
Fluvoxamine—Insomnia—Entecavir—hepatitis B	0.00265	0.00368	CcSEcCtD
Fluvoxamine—Mood swings—Lamivudine—hepatitis B	0.00262	0.00363	CcSEcCtD
Fluvoxamine—Somnolence—Entecavir—hepatitis B	0.00261	0.00362	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00261	0.00362	CcSEcCtD
Fluvoxamine—Dyspepsia—Entecavir—hepatitis B	0.00258	0.00359	CcSEcCtD
Fluvoxamine—Cough—Telbivudine—hepatitis B	0.00258	0.00358	CcSEcCtD
Fluvoxamine—Dehydration—Lamivudine—hepatitis B	0.00257	0.00357	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Lamivudine—hepatitis B	0.00255	0.00354	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00253	0.00352	CcSEcCtD
Fluvoxamine—Fatigue—Entecavir—hepatitis B	0.00253	0.00351	CcSEcCtD
Fluvoxamine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00252	0.0035	CcSEcCtD
Fluvoxamine—Chest pain—Telbivudine—hepatitis B	0.00251	0.00349	CcSEcCtD
Fluvoxamine—Myalgia—Telbivudine—hepatitis B	0.00251	0.00349	CcSEcCtD
Fluvoxamine—Arthralgia—Telbivudine—hepatitis B	0.00251	0.00349	CcSEcCtD
Fluvoxamine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00249	0.00345	CcSEcCtD
Fluvoxamine—Discomfort—Telbivudine—hepatitis B	0.00248	0.00345	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00247	0.00343	CcSEcCtD
Fluvoxamine—CYP2C19—blood—hepatitis B	0.00247	0.0246	CbGeAlD
Fluvoxamine—Muscular weakness—Lamivudine—hepatitis B	0.00244	0.00338	CcSEcCtD
Fluvoxamine—Abdominal distension—Lamivudine—hepatitis B	0.0024	0.00334	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Entecavir—hepatitis B	0.0024	0.00333	CcSEcCtD
Fluvoxamine—Influenza—Lamivudine—hepatitis B	0.00239	0.00332	CcSEcCtD
Fluvoxamine—Dysphagia—Lamivudine—hepatitis B	0.00239	0.00332	CcSEcCtD
Fluvoxamine—Nervous system disorder—Telbivudine—hepatitis B	0.00236	0.00328	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Telbivudine—hepatitis B	0.00236	0.00328	CcSEcCtD
Fluvoxamine—Pancreatitis—Lamivudine—hepatitis B	0.00234	0.00325	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00234	0.00325	CcSEcCtD
Fluvoxamine—Sweating increased—Lamivudine—hepatitis B	0.00233	0.00323	CcSEcCtD
Fluvoxamine—Body temperature increased—Entecavir—hepatitis B	0.00232	0.00322	CcSEcCtD
Fluvoxamine—Abdominal pain—Entecavir—hepatitis B	0.00232	0.00322	CcSEcCtD
Fluvoxamine—SIGMAR1—liver—hepatitis B	0.00231	0.0231	CbGeAlD
Fluvoxamine—Bronchitis—Lamivudine—hepatitis B	0.0023	0.00319	CcSEcCtD
Fluvoxamine—Abdominal discomfort—Lamivudine—hepatitis B	0.00229	0.00318	CcSEcCtD
Fluvoxamine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00226	0.00314	CcSEcCtD
Fluvoxamine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00226	0.00314	CcSEcCtD
Fluvoxamine—Dysuria—Lamivudine—hepatitis B	0.00223	0.0031	CcSEcCtD
Fluvoxamine—Pollakiuria—Lamivudine—hepatitis B	0.00221	0.00306	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.0022	0.00305	CcSEcCtD
Fluvoxamine—Insomnia—Telbivudine—hepatitis B	0.00218	0.00303	CcSEcCtD
Fluvoxamine—Paraesthesia—Telbivudine—hepatitis B	0.00216	0.003	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Lamivudine—hepatitis B	0.00215	0.00299	CcSEcCtD
Fluvoxamine—Depression—Lamivudine—hepatitis B	0.00212	0.00295	CcSEcCtD
Fluvoxamine—Dyspepsia—Telbivudine—hepatitis B	0.00212	0.00295	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00211	0.00293	CcSEcCtD
Fluvoxamine—Asthenia—Entecavir—hepatitis B	0.0021	0.00292	CcSEcCtD
Fluvoxamine—Renal failure—Lamivudine—hepatitis B	0.00209	0.00291	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Lamivudine—hepatitis B	0.00209	0.0029	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00208	0.00289	CcSEcCtD
Fluvoxamine—Fatigue—Telbivudine—hepatitis B	0.00208	0.00288	CcSEcCtD
Fluvoxamine—Jaundice—Lamivudine—hepatitis B	0.00208	0.00288	CcSEcCtD
Fluvoxamine—Stomatitis—Lamivudine—hepatitis B	0.00208	0.00288	CcSEcCtD
Fluvoxamine—Pain—Telbivudine—hepatitis B	0.00206	0.00286	CcSEcCtD
Fluvoxamine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00205	0.00285	CcSEcCtD
Fluvoxamine—Sweating—Lamivudine—hepatitis B	0.00204	0.00283	CcSEcCtD
Fluvoxamine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00202	0.00281	CcSEcCtD
Fluvoxamine—CYP1A2—blood—hepatitis B	0.00201	0.0201	CbGeAlD
Fluvoxamine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00201	0.0028	CcSEcCtD
Fluvoxamine—Epistaxis—Lamivudine—hepatitis B	0.00201	0.00279	CcSEcCtD
Fluvoxamine—Diarrhoea—Entecavir—hepatitis B	0.00201	0.00279	CcSEcCtD
Fluvoxamine—Sinusitis—Lamivudine—hepatitis B	0.002	0.00277	CcSEcCtD
Fluvoxamine—CYP1A1—blood—hepatitis B	0.00199	0.0198	CbGeAlD
Fluvoxamine—Agranulocytosis—Lamivudine—hepatitis B	0.00199	0.00276	CcSEcCtD
Fluvoxamine—Feeling abnormal—Telbivudine—hepatitis B	0.00199	0.00276	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00197	0.00274	CcSEcCtD
Fluvoxamine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00196	0.00272	CcSEcCtD
Fluvoxamine—CYP3A5—blood—hepatitis B	0.00194	0.0194	CbGeAlD
Fluvoxamine—Dizziness—Entecavir—hepatitis B	0.00194	0.00269	CcSEcCtD
Fluvoxamine—CYP2B6—blood—hepatitis B	0.00193	0.0193	CbGeAlD
Fluvoxamine—CYP2C19—liver—hepatitis B	0.00193	0.0193	CbGeAlD
Fluvoxamine—Rhinitis—Lamivudine—hepatitis B	0.00192	0.00266	CcSEcCtD
Fluvoxamine—CYP2C9—blood—hepatitis B	0.00191	0.0191	CbGeAlD
Fluvoxamine—Hepatitis—Lamivudine—hepatitis B	0.00191	0.00265	CcSEcCtD
Fluvoxamine—Body temperature increased—Telbivudine—hepatitis B	0.0019	0.00264	CcSEcCtD
Fluvoxamine—Abdominal pain—Telbivudine—hepatitis B	0.0019	0.00264	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Lamivudine—hepatitis B	0.0019	0.00264	CcSEcCtD
Fluvoxamine—Pharyngitis—Lamivudine—hepatitis B	0.0019	0.00263	CcSEcCtD
Fluvoxamine—Vomiting—Entecavir—hepatitis B	0.00186	0.00259	CcSEcCtD
Fluvoxamine—Rash—Entecavir—hepatitis B	0.00185	0.00257	CcSEcCtD
Fluvoxamine—Dermatitis—Entecavir—hepatitis B	0.00185	0.00257	CcSEcCtD
Fluvoxamine—Headache—Entecavir—hepatitis B	0.00184	0.00255	CcSEcCtD
Fluvoxamine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00182	0.00253	CcSEcCtD
Fluvoxamine—CYP2E1—blood—hepatitis B	0.00181	0.0181	CbGeAlD
Fluvoxamine—Erythema multiforme—Lamivudine—hepatitis B	0.00181	0.00251	CcSEcCtD
Fluvoxamine—Rash—Adefovir Dipivoxil—hepatitis B	0.0018	0.00251	CcSEcCtD
Fluvoxamine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0018	0.0025	CcSEcCtD
Fluvoxamine—Headache—Adefovir Dipivoxil—hepatitis B	0.00179	0.00249	CcSEcCtD
Fluvoxamine—Nausea—Entecavir—hepatitis B	0.00174	0.00242	CcSEcCtD
Fluvoxamine—Asthenia—Telbivudine—hepatitis B	0.00173	0.0024	CcSEcCtD
Fluvoxamine—Chills—Lamivudine—hepatitis B	0.00171	0.00238	CcSEcCtD
Fluvoxamine—Pruritus—Telbivudine—hepatitis B	0.0017	0.00237	CcSEcCtD
Fluvoxamine—Nausea—Adefovir Dipivoxil—hepatitis B	0.0017	0.00236	CcSEcCtD
Fluvoxamine—Alopecia—Lamivudine—hepatitis B	0.00169	0.00235	CcSEcCtD
Fluvoxamine—Malnutrition—Lamivudine—hepatitis B	0.00166	0.00231	CcSEcCtD
Fluvoxamine—Diarrhoea—Telbivudine—hepatitis B	0.00165	0.00229	CcSEcCtD
Fluvoxamine—Flatulence—Lamivudine—hepatitis B	0.00164	0.00228	CcSEcCtD
Fluvoxamine—Tension—Lamivudine—hepatitis B	0.00163	0.00227	CcSEcCtD
Fluvoxamine—Dysgeusia—Lamivudine—hepatitis B	0.00163	0.00226	CcSEcCtD
Fluvoxamine—Nervousness—Lamivudine—hepatitis B	0.00162	0.00224	CcSEcCtD
Fluvoxamine—Back pain—Lamivudine—hepatitis B	0.00161	0.00223	CcSEcCtD
Fluvoxamine—Muscle spasms—Lamivudine—hepatitis B	0.0016	0.00222	CcSEcCtD
Fluvoxamine—Dizziness—Telbivudine—hepatitis B	0.00159	0.00221	CcSEcCtD
Fluvoxamine—CYP1A2—liver—hepatitis B	0.00158	0.0157	CbGeAlD
Fluvoxamine—Tremor—Lamivudine—hepatitis B	0.00156	0.00216	CcSEcCtD
Fluvoxamine—CYP1A1—liver—hepatitis B	0.00155	0.0155	CbGeAlD
Fluvoxamine—Ill-defined disorder—Lamivudine—hepatitis B	0.00154	0.00214	CcSEcCtD
Fluvoxamine—Anaemia—Lamivudine—hepatitis B	0.00154	0.00214	CcSEcCtD
Fluvoxamine—Vomiting—Telbivudine—hepatitis B	0.00153	0.00213	CcSEcCtD
Fluvoxamine—Angioedema—Lamivudine—hepatitis B	0.00152	0.00211	CcSEcCtD
Fluvoxamine—CYP3A5—liver—hepatitis B	0.00152	0.0152	CbGeAlD
Fluvoxamine—Rash—Telbivudine—hepatitis B	0.00152	0.00211	CcSEcCtD
Fluvoxamine—Dermatitis—Telbivudine—hepatitis B	0.00152	0.00211	CcSEcCtD
Fluvoxamine—CYP2B6—liver—hepatitis B	0.00151	0.0151	CbGeAlD
Fluvoxamine—Headache—Telbivudine—hepatitis B	0.00151	0.0021	CcSEcCtD
Fluvoxamine—Malaise—Lamivudine—hepatitis B	0.0015	0.00208	CcSEcCtD
Fluvoxamine—CYP2C9—liver—hepatitis B	0.0015	0.0149	CbGeAlD
Fluvoxamine—Vertigo—Lamivudine—hepatitis B	0.00149	0.00208	CcSEcCtD
Fluvoxamine—Syncope—Lamivudine—hepatitis B	0.00149	0.00207	CcSEcCtD
Fluvoxamine—Leukopenia—Lamivudine—hepatitis B	0.00149	0.00207	CcSEcCtD
Fluvoxamine—Loss of consciousness—Lamivudine—hepatitis B	0.00146	0.00203	CcSEcCtD
Fluvoxamine—CYP3A4—blood—hepatitis B	0.00146	0.0146	CbGeAlD
Fluvoxamine—Cough—Lamivudine—hepatitis B	0.00145	0.00202	CcSEcCtD
Fluvoxamine—Convulsion—Lamivudine—hepatitis B	0.00144	0.002	CcSEcCtD
Fluvoxamine—CYP2D6—blood—hepatitis B	0.00143	0.0143	CbGeAlD
Fluvoxamine—Nausea—Telbivudine—hepatitis B	0.00143	0.00199	CcSEcCtD
Fluvoxamine—CYP2E1—liver—hepatitis B	0.00142	0.0142	CbGeAlD
Fluvoxamine—Arthralgia—Lamivudine—hepatitis B	0.00142	0.00197	CcSEcCtD
Fluvoxamine—Myalgia—Lamivudine—hepatitis B	0.00142	0.00197	CcSEcCtD
Fluvoxamine—Chest pain—Lamivudine—hepatitis B	0.00142	0.00197	CcSEcCtD
Fluvoxamine—Anxiety—Lamivudine—hepatitis B	0.00141	0.00196	CcSEcCtD
Fluvoxamine—Discomfort—Lamivudine—hepatitis B	0.0014	0.00194	CcSEcCtD
Fluvoxamine—Dry mouth—Lamivudine—hepatitis B	0.00139	0.00192	CcSEcCtD
Fluvoxamine—Confusional state—Lamivudine—hepatitis B	0.00137	0.0019	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Lamivudine—hepatitis B	0.00136	0.00189	CcSEcCtD
Fluvoxamine—Oedema—Lamivudine—hepatitis B	0.00136	0.00189	CcSEcCtD
Fluvoxamine—Infection—Lamivudine—hepatitis B	0.00135	0.00187	CcSEcCtD
Fluvoxamine—Shock—Lamivudine—hepatitis B	0.00134	0.00186	CcSEcCtD
Fluvoxamine—Nervous system disorder—Lamivudine—hepatitis B	0.00133	0.00185	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Lamivudine—hepatitis B	0.00133	0.00185	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Lamivudine—hepatitis B	0.00131	0.00182	CcSEcCtD
Fluvoxamine—Anorexia—Lamivudine—hepatitis B	0.00129	0.0018	CcSEcCtD
Fluvoxamine—Hypotension—Lamivudine—hepatitis B	0.00127	0.00176	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00124	0.00172	CcSEcCtD
Fluvoxamine—Insomnia—Lamivudine—hepatitis B	0.00123	0.00171	CcSEcCtD
Fluvoxamine—Paraesthesia—Lamivudine—hepatitis B	0.00122	0.00169	CcSEcCtD
Fluvoxamine—Dyspnoea—Lamivudine—hepatitis B	0.00121	0.00168	CcSEcCtD
Fluvoxamine—Somnolence—Lamivudine—hepatitis B	0.00121	0.00168	CcSEcCtD
Fluvoxamine—Dyspepsia—Lamivudine—hepatitis B	0.0012	0.00166	CcSEcCtD
Fluvoxamine—Decreased appetite—Lamivudine—hepatitis B	0.00118	0.00164	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00117	0.00163	CcSEcCtD
Fluvoxamine—Fatigue—Lamivudine—hepatitis B	0.00117	0.00163	CcSEcCtD
Fluvoxamine—Pain—Lamivudine—hepatitis B	0.00116	0.00161	CcSEcCtD
Fluvoxamine—Constipation—Lamivudine—hepatitis B	0.00116	0.00161	CcSEcCtD
Fluvoxamine—CYP3A4—liver—hepatitis B	0.00114	0.0114	CbGeAlD
Fluvoxamine—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00113	0.0063	CbGpPWpGaD
Fluvoxamine—CYP2D6—liver—hepatitis B	0.00112	0.0112	CbGeAlD
Fluvoxamine—Feeling abnormal—Lamivudine—hepatitis B	0.00112	0.00155	CcSEcCtD
Fluvoxamine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00112	0.00622	CbGpPWpGaD
Fluvoxamine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00111	0.00154	CcSEcCtD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.00111	0.00616	CbGpPWpGaD
Fluvoxamine—Urticaria—Lamivudine—hepatitis B	0.00108	0.0015	CcSEcCtD
Fluvoxamine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00108	0.00599	CbGpPWpGaD
Fluvoxamine—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00107	0.00598	CbGpPWpGaD
Fluvoxamine—Abdominal pain—Lamivudine—hepatitis B	0.00107	0.00149	CcSEcCtD
Fluvoxamine—Body temperature increased—Lamivudine—hepatitis B	0.00107	0.00149	CcSEcCtD
Fluvoxamine—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00103	0.00575	CbGpPWpGaD
Fluvoxamine—ABCB1—blood—hepatitis B	0.00103	0.0103	CbGeAlD
Fluvoxamine—Hypersensitivity—Lamivudine—hepatitis B	0.001	0.00139	CcSEcCtD
Fluvoxamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000982	0.00546	CbGpPWpGaD
Fluvoxamine—Asthenia—Lamivudine—hepatitis B	0.000974	0.00135	CcSEcCtD
Fluvoxamine—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	0.000971	0.0054	CbGpPWpGaD
Fluvoxamine—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000969	0.00539	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—KCNH1—hepatitis B	0.000968	0.00539	CbGpPWpGaD
Fluvoxamine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000962	0.00535	CbGpPWpGaD
Fluvoxamine—Pruritus—Lamivudine—hepatitis B	0.000961	0.00133	CcSEcCtD
Fluvoxamine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00096	0.00534	CbGpPWpGaD
Fluvoxamine—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000949	0.00528	CbGpPWpGaD
Fluvoxamine—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000947	0.00527	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—GGT2—hepatitis B	0.000944	0.00525	CbGpPWpGaD
Fluvoxamine—SLC6A4—NRF2 pathway—CYP2A6—hepatitis B	0.000939	0.00522	CbGpPWpGaD
Fluvoxamine—Diarrhoea—Lamivudine—hepatitis B	0.000929	0.00129	CcSEcCtD
Fluvoxamine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000907	0.00505	CbGpPWpGaD
Fluvoxamine—Dizziness—Lamivudine—hepatitis B	0.000898	0.00125	CcSEcCtD
Fluvoxamine—CYP1A1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000895	0.00498	CbGpPWpGaD
Fluvoxamine—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000874	0.00486	CbGpPWpGaD
Fluvoxamine—Vomiting—Lamivudine—hepatitis B	0.000863	0.0012	CcSEcCtD
Fluvoxamine—Rash—Lamivudine—hepatitis B	0.000856	0.00119	CcSEcCtD
Fluvoxamine—Dermatitis—Lamivudine—hepatitis B	0.000855	0.00119	CcSEcCtD
Fluvoxamine—Headache—Lamivudine—hepatitis B	0.000851	0.00118	CcSEcCtD
Fluvoxamine—CYP1A1—Arachidonic acid metabolism—GGT1—hepatitis B	0.000819	0.00456	CbGpPWpGaD
Fluvoxamine—ABCB1—liver—hepatitis B	0.000807	0.00806	CbGeAlD
Fluvoxamine—Nausea—Lamivudine—hepatitis B	0.000807	0.00112	CcSEcCtD
Fluvoxamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000796	0.00443	CbGpPWpGaD
Fluvoxamine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00078	0.00434	CbGpPWpGaD
Fluvoxamine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000778	0.00433	CbGpPWpGaD
Fluvoxamine—SLC6A4—Monoamine Transport—TNF—hepatitis B	0.000776	0.00432	CbGpPWpGaD
Fluvoxamine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000742	0.00413	CbGpPWpGaD
Fluvoxamine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000738	0.00411	CbGpPWpGaD
Fluvoxamine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000735	0.00409	CbGpPWpGaD
Fluvoxamine—SLC6A4—NRF2 pathway—GGT1—hepatitis B	0.000733	0.00408	CbGpPWpGaD
Fluvoxamine—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000732	0.00407	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000718	0.004	CbGpPWpGaD
Fluvoxamine—SLC6A3—NRF2 pathway—CYP2A6—hepatitis B	0.000715	0.00398	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000714	0.00397	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000703	0.00391	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.000702	0.00391	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000702	0.0039	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—GGT2—hepatitis B	0.000698	0.00388	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—GGT2—hepatitis B	0.000684	0.0038	CbGpPWpGaD
Fluvoxamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000682	0.0038	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000682	0.0038	CbGpPWpGaD
Fluvoxamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000677	0.00376	CbGpPWpGaD
Fluvoxamine—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000674	0.00375	CbGpPWpGaD
Fluvoxamine—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.00067	0.00373	CbGpPWpGaD
Fluvoxamine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000668	0.00372	CbGpPWpGaD
Fluvoxamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—hepatitis B	0.000666	0.00371	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000663	0.00369	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—GGT2—hepatitis B	0.000644	0.00359	CbGpPWpGaD
Fluvoxamine—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000611	0.0034	CbGpPWpGaD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000602	0.00335	CbGpPWpGaD
Fluvoxamine—SLC6A3—Monoamine Transport—TNF—hepatitis B	0.000591	0.00329	CbGpPWpGaD
Fluvoxamine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000578	0.00322	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000574	0.00319	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	0.000572	0.00318	CbGpPWpGaD
Fluvoxamine—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000571	0.00317	CbGpPWpGaD
Fluvoxamine—SLC6A3—NRF2 pathway—GGT1—hepatitis B	0.000558	0.00311	CbGpPWpGaD
Fluvoxamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000553	0.00308	CbGpPWpGaD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000548	0.00305	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000543	0.00302	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000527	0.00293	CbGpPWpGaD
Fluvoxamine—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000522	0.00291	CbGpPWpGaD
Fluvoxamine—CYP1A1—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000511	0.00285	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000508	0.00283	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000499	0.00278	CbGpPWpGaD
Fluvoxamine—CYP1A1—Oxidative Stress—NFKB1—hepatitis B	0.000498	0.00277	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000495	0.00275	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000485	0.0027	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000481	0.00268	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000469	0.00261	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—GGT1—hepatitis B	0.000446	0.00248	CbGpPWpGaD
Fluvoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000446	0.00248	CbGpPWpGaD
Fluvoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00044	0.00245	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000425	0.00236	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—CYP2A6—hepatitis B	0.000423	0.00235	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000423	0.00235	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—FAS—hepatitis B	0.00042	0.00234	CbGpPWpGaD
Fluvoxamine—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000419	0.00233	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—CYP2A6—hepatitis B	0.000414	0.0023	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.000413	0.0023	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000411	0.00229	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—CYP2A6—hepatitis B	0.00039	0.00217	CbGpPWpGaD
Fluvoxamine—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000385	0.00214	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000378	0.0021	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000374	0.00208	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000374	0.00208	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000362	0.00201	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—NOS2—hepatitis B	0.000359	0.002	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000356	0.00198	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000354	0.00197	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000348	0.00194	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000336	0.00187	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000332	0.00185	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000332	0.00184	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—GGT1—hepatitis B	0.00033	0.00184	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.00033	0.00184	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000326	0.00182	CbGpPWpGaD
Fluvoxamine—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000326	0.00181	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—GGT1—hepatitis B	0.000323	0.0018	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000323	0.0018	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.00032	0.00178	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000317	0.00176	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000305	0.0017	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—GGT1—hepatitis B	0.000305	0.0017	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000302	0.00168	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000295	0.00164	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000294	0.00164	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000291	0.00162	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000289	0.00161	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000281	0.00156	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000275	0.00153	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000275	0.00153	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000271	0.00151	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000258	0.00144	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000249	0.00139	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000249	0.00139	CbGpPWpGaD
Fluvoxamine—SLC6A4—NRF2 pathway—TGFB1—hepatitis B	0.000247	0.00137	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000241	0.00134	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—PTEN—hepatitis B	0.00023	0.00128	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000229	0.00128	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000227	0.00127	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000227	0.00126	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000225	0.00125	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.00022	0.00123	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000218	0.00122	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000211	0.00118	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000196	0.00109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000194	0.00108	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000193	0.00107	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000192	0.00107	CbGpPWpGaD
Fluvoxamine—SLC6A3—NRF2 pathway—TGFB1—hepatitis B	0.000188	0.00105	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000188	0.00105	CbGpPWpGaD
Fluvoxamine—SLC6A3—SLC-mediated transmembrane transport—ALB—hepatitis B	0.000187	0.00104	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000176	0.000981	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000175	0.000976	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000175	0.000976	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000172	0.000956	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKR1B1—hepatitis B	0.000168	0.000937	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000166	0.000922	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000165	0.000916	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GGT2—hepatitis B	0.000161	0.000898	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	0.000157	0.000875	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000153	0.000849	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.00015	0.000835	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	0.000144	0.000801	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000143	0.000793	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKR1B1—hepatitis B	0.000124	0.000693	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKR1B1—hepatitis B	0.000122	0.000678	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKR1B1—hepatitis B	0.000122	0.000677	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GGT2—hepatitis B	0.000119	0.000664	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000117	0.000651	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GGT2—hepatitis B	0.000117	0.00065	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GGT2—hepatitis B	0.000117	0.000649	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKR1B1—hepatitis B	0.000115	0.00064	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GGT2—hepatitis B	0.00011	0.000613	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP2A6—hepatitis B	9.78e-05	0.000544	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.58e-05	0.000533	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—ALB—hepatitis B	9.51e-05	0.000529	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKR1B1—hepatitis B	9.41e-05	0.000523	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	9.32e-05	0.000519	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKR1B1—hepatitis B	9.18e-05	0.000511	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	9.11e-05	0.000507	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	9.09e-05	0.000506	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	9.04e-05	0.000503	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GGT2—hepatitis B	9.02e-05	0.000502	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GOT2—hepatitis B	8.84e-05	0.000492	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GGT2—hepatitis B	8.8e-05	0.00049	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.73e-05	0.000486	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKR1B1—hepatitis B	8.65e-05	0.000481	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKR1B1—hepatitis B	8.58e-05	0.000477	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GGT2—hepatitis B	8.3e-05	0.000462	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GGT2—hepatitis B	8.22e-05	0.000458	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GGT1—hepatitis B	7.63e-05	0.000425	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GOT1—hepatitis B	7.63e-05	0.000425	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	7.53e-05	0.000419	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.46e-05	0.000415	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKR1B1—hepatitis B	7.33e-05	0.000408	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2A6—hepatitis B	7.23e-05	0.000402	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP2A6—hepatitis B	7.08e-05	0.000394	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2A6—hepatitis B	7.07e-05	0.000393	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	7.03e-05	0.000391	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT2—hepatitis B	7.03e-05	0.000391	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2A6—hepatitis B	6.68e-05	0.000372	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GOT2—hepatitis B	6.54e-05	0.000364	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GOT2—hepatitis B	6.41e-05	0.000356	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GOT2—hepatitis B	6.39e-05	0.000356	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.23e-05	0.000346	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	6.2e-05	0.000345	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GOT2—hepatitis B	6.04e-05	0.000336	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.66e-05	0.000315	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GOT1—hepatitis B	5.65e-05	0.000314	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GGT1—hepatitis B	5.65e-05	0.000314	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GOT1—hepatitis B	5.53e-05	0.000308	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GGT1—hepatitis B	5.53e-05	0.000308	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GOT1—hepatitis B	5.52e-05	0.000307	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GGT1—hepatitis B	5.52e-05	0.000307	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2A6—hepatitis B	5.46e-05	0.000304	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT2—hepatitis B	5.42e-05	0.000302	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2A6—hepatitis B	5.33e-05	0.000297	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GGT1—hepatitis B	5.21e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GOT1—hepatitis B	5.21e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.09e-05	0.000284	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP2A6—hepatitis B	5.03e-05	0.00028	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2A6—hepatitis B	4.98e-05	0.000277	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GOT2—hepatitis B	4.94e-05	0.000275	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GOT2—hepatitis B	4.82e-05	0.000268	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.75e-05	0.000264	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	4.73e-05	0.000263	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.65e-05	0.000259	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GOT2—hepatitis B	4.55e-05	0.000253	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GOT2—hepatitis B	4.51e-05	0.000251	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GOT1—hepatitis B	4.27e-05	0.000237	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GGT1—hepatitis B	4.27e-05	0.000237	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2A6—hepatitis B	4.26e-05	0.000237	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GGT1—hepatitis B	4.16e-05	0.000232	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GOT1—hepatitis B	4.16e-05	0.000232	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—hepatitis B	4.06e-05	0.000226	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.97e-05	0.000221	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GGT1—hepatitis B	3.92e-05	0.000218	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GOT1—hepatitis B	3.92e-05	0.000218	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GOT1—hepatitis B	3.89e-05	0.000216	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GGT1—hepatitis B	3.89e-05	0.000216	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.89e-05	0.000216	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT2—hepatitis B	3.85e-05	0.000214	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.54e-05	0.000197	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT1—hepatitis B	3.32e-05	0.000185	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT1—hepatitis B	3.32e-05	0.000185	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.29e-05	0.000183	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—hepatitis B	3.1e-05	0.000172	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.03e-05	0.000169	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—hepatitis B	3e-05	0.000167	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT2—hepatitis B	2.97e-05	0.000165	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—hepatitis B	2.94e-05	0.000164	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—hepatitis B	2.93e-05	0.000163	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—hepatitis B	2.77e-05	0.000154	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT1—hepatitis B	2.57e-05	0.000143	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT1—hepatitis B	2.57e-05	0.000143	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—hepatitis B	2.29e-05	0.000127	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—hepatitis B	2.27e-05	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—hepatitis B	2.24e-05	0.000125	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—hepatitis B	2.24e-05	0.000125	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—hepatitis B	2.21e-05	0.000123	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—hepatitis B	2.12e-05	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—hepatitis B	2.09e-05	0.000116	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—hepatitis B	2.07e-05	0.000115	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—hepatitis B	1.77e-05	9.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—hepatitis B	1.73e-05	9.63e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—hepatitis B	1.69e-05	9.4e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—hepatitis B	1.59e-05	8.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—hepatitis B	1.58e-05	8.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—hepatitis B	1.36e-05	7.59e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—hepatitis B	1.35e-05	7.51e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—hepatitis B	1.04e-05	5.79e-05	CbGpPWpGaD
